PP
KURA icon

PDT Partners’s Kura Oncology KURA Stock Holding History

PDT Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,810
Closed -$981K – 772
2022
Q3 		$981K Sell
71,810
-16,407
-19% -$253K 0.15% 224
2022
Q2 		$1.62M Buy
88,217
+150
+0.2% +$2.16K 0.14% 227
2022
Q1 		$1.42M Buy
88,067
+67,007
+318% +$968K 0.12% 261
2021
Q4 		$295K Buy
+21,060
New +$341K 0.02% 671
2020
Q3 		– Sell
-11,334
Closed -$185K – 793
2020
Q2 		$185K Sell
11,334
-43,067
-79% -$621K 0.01% 601
2020
Q1 		$541K Buy
54,401
+10,836
+25% +$124K 0.04% 352
2019
Q4 		$599K Buy
43,565
+16,724
+62% +$248K 0.04% 378
2019
Q3 		$407K Buy
26,841
+5,841
+28% +$104K 0.02% 354
2019
Q2 		$413K Buy
+21,000
New +$349K 0.02% 315

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PDT Partners's KURA Position: Q4 2022 in Review

PDT Partners sold out of Kura Oncology (KURA) in Q4 2022, closing a stake of 71,810 shares — an estimated $981K sold.

PDT Partners first reported a position in KURA in Q2 2019 and held it in 9 quarters. The position peaked at $1.62M in Q2 2022. 142 funds tracked by Wall St. Rank hold KURA as of Q4 2022.

  • PDT Partners reported no remaining Kura Oncology position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 71,810 Kura Oncology shares in Q4 2022, an estimated $981K.
  • PDT Partners first reported a position in Kura Oncology in Q2 2019 and held it in 9 quarters.
  • PDT Partners's Kura Oncology position peaked at $1.62M in Q2 2022.
  • 142 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.